CLXT Calyxt

Calyxt Appoints Dr. Travis Frey as Chief Technology Officer

(NASDAQ: CLXT), a healthy food ingredient company, announced today the appointment of Dr. Travis Frey as Chief Technology Officer, effective May 20, 2019. Dr. Frey brings his extensive knowledge in plant biology and biotechnology to a newly created position at the Company. As CTO, Dr. Frey will be responsible for the Research and Development team to propel product development and its pipeline of healthier food ingredients.

“With over 15 years of agricultural industry and technology innovation experience, Travis will be an excellent asset to complement the Calyxt team as we grow and assess our business needs,” said Jim Blome, Chief Executive Officer of Calyxt. “Travis has a well-rounded background in the field, and I’m confident that in partnership with our Chief Science Officer, Prof. Dan Voytas, he will be a critical voice in our continuous evaluation of our food ingredient pipeline.”

Dr. Travis Frey received his B.S. in Horticulture from Penn State University, followed by his M.S. in Plant Breeding and Plant Genetics from University of Wisconsin. He later obtained his Ph.D. in the Plant Biology and Biotechnology Program at the University of Delaware and DuPont/Pioneer and an M.B.A from the University of Chicago – Booth School of Business. Prior to joining Calyxt, Dr. Frey’s most recent role was with WISErg Corporation as their Vice President of Science and Innovation, where he was responsible for developing and championing the science and technology vision, strategy and execution of company initiatives. Dr. Frey’s past experience also includes various positions with Monsanto, including Controlled Environment Facility Director, Global Dicot Transformation Facility Director, Genome Wide Genotyping and Platform Innovation Lead and Trait Integration Innovation Lead.

“I’m thrilled to be joining a company that uses cutting-edge breeding techniques and forward-thinking to stay ahead of the curve when it comes to innovation in its business,” commented Dr. Travis Frey. “I look forward to partnering with Prof. Dan Voytas and contributing my experience to help Calyxt remain at the forefront of developing healthier food ingredients for consumers.”

Kincannon & Reed, a leading executive search firm focused on the food, agribusiness, and biosciences sectors, assisted Calyxt in the recruitment of its Chief Technology Officer.

About Calyxt

Calyxt is committed to making the food you love a healthier choice. The care we take extends beyond nutritional value. We partner with farmers and food companies to deliver traceable plant-based products developed to be healthier and more sustainable than their conventional counterparts. We use cutting edge plant breeding techniques to develop products that help improve diets by reducing bad fats, allergens and toxins. Today oil from our high oleic soybean plants has lower saturated fats than commodity soybean oil. We are also developing high fiber wheat designed to provide an excellent source of daily fiber when incorporated into wheat-based foods. We continuously pursue innovation to deliver good food that is good for you.

Calyxt is located in Roseville, MN, and is listed on the Nasdaq market (ticker: CLXT). For further information please visit our website at .

Calyxt™ and the corporate logo are trademarks owned by Calyxt, Inc.

Forward-Looking Statements

This communication may contain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue,” the negative of these terms and other comparable terminology. These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including those factors discussed under the caption entitled “Risk Factors” in Calyxt’s Annual Report on Form 10-K for the year ended December 31, 2018 along with other Calyxt subsequent filings with the U.S. Securities and Exchange Commission. We do not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by applicable laws.

EN
15/05/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Calyxt

Calyxt Inc: 1 director

A director at Calyxt Inc bought 20,000 shares at 3.206USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Calyxt to Host Fourth Quarter and Full Year 2020 Financial Results Con...

ROSEVILLE, Minn.--(BUSINESS WIRE)-- (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, March 4, 2021 at 4:30 p.m. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2020. A press release detailing these results will be issued prior to the call. Calyxt Chief Executive Officer Jim Blome and Chief Financial Officer Bill Koschak will host the conference call, followed by a question-and-answer session. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via th...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Calyxt to Host Third Quarter 2019 Results Conference Call on Wednesday...

ROSEVILLE, Minn.--(BUSINESS WIRE)-- (NASDAQ: CLXT), a plant-based breeding and technology platform company, will hold a conference call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2019. A press release detailing these results will be issued prior to the call. Calyxt Chief Executive Officer Jim Blome, Chief Financial Officer Bill Koschak, Chief Business Development and Supply Chain Officer Manoj Sahoo and Senior Vice President of Sales & Marketing Keith Blanks will host the conference call, followed by a question a...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch